We were interested whether the genomic breakpoints of TERT rearrangements have sequences that are unique to the neuroblastoma or metastases in a single patient, thus presenting precise target sequences capable of monitoring disease in serial liquid biopsies. Here, TERT is linked to neuroblastoma.